Our results here showed that nc886 silencing occurred in some thyroid cancer cells (Supplementary Figure S2) as reported in other types of cancer [7–10] and that nc886 KD activated PKR (Figure 2). The gene discussed is EIF2AK2; the disease is thyroid gland carcinoma.